Biodexa Pharmaceuticals Plc
BDRX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,729 | -$7,079 | -$7,656 | -$5,460 |
| Dep. & Amort. | $254 | $283 | $343 | $403 |
| Deferred Tax | -$250 | -$406 | -$832 | $469 |
| Stock-Based Comp. | $283 | $28 | $123 | $89 |
| Change in WC | -$3,736 | -$49 | $520 | -$617 |
| Other Non-Cash | -$3,083 | $397 | $454 | -$892 |
| Operating Cash Flow | -$12,261 | -$6,826 | -$7,048 | -$6,008 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9 | -$26 | -$62 | -$320 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$589 | -$239 | -$158 | $42 |
| Investing Cash Flow | -$598 | -$265 | -$220 | -$278 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $245 | -$188 | -$178 | -$215 |
| Stock Issued | $8,312 | $10,427 | $243 | $9,035 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$13 | -$18 | -$15 |
| Financing Cash Flow | $8,557 | $10,226 | $47 | $8,805 |
| Forex Effect | $0 | $0 | $0 | -$8 |
| Net Chg. in Cash | -$4,302 | $3,135 | -$7,221 | $2,511 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $5,971 | $2,836 | $10,057 | $7,546 |
| End Cash | $1,669 | $5,971 | $2,836 | $10,057 |
| Free Cash Flow | -$13,035 | -$7,089 | -$7,110 | -$6,328 |